Beskrywing

The neurointerventional procedural medical device market in China in terms of revenue is set to grow by US$ 2 miljard tydens 2021-2027, groei teen 'n saamgestelde jaarlikse groeikoers (CAGR) van 20.1% gedurende die voorspellingsperiode, volgens die data- en ontledingsmaatskappy StrategyHelix.

Die verslag verskaf up-to-date markgrootte data vir tydperk 2017-2020 en voorspel tot 2027 covering key market aspects like sales value for neurointerventional procedural medical device. The China neurointerventional procedural medical device market is segmented on the basis of type. Volgens tipe, it is categorized into hemorrhage, and ischemia.

The report has profiled some of the key players of the market such as MicroPort Scientific Corporation, Medtronic plc, Penumbra Inc., Stryker Corporation.

Die verslag is 'n waardevolle hulpbron vir maatskappye en organisasies wat in hierdie bedryf aktief is. It provides a cohesive picture of the neurointerventional procedural medical device market to help drive informed decision making for industry executives, beleidmakers, akademies, en ontleders.

Verslag Omvang

Tik: hemorrhage, and ischemia
Jare oorweeg: hierdie verslag dek die tydperk 2017 aan 2027

Sleutelvoordele vir belanghebbendes

Get a comprehensive picture of the China neurointerventional procedural medical device market
Bepaal groeisektore en -neigings vir belegging
Understand what the future of the neurointerventional procedural medical device market in China looks like
Identifiseer die mededingende landskap en geleentheidsvenster

INHOUDSOPGAWE

1. Markdefinisie
2. Navorsingsmetodologie
3. Markdata & Outlook
3.1 Markwaarde
3.2 Markwaarde Voorspelling
4. Neurointerventional Procedural Medical Device Market by Type
4.1 Hemorrhage
4.2 Ischemia
5. Maatskappy profiele
5.1 MicroPort Scientific Corporation
5.2 Medtronic plc
5.3 Penumbra, Inc.
5.4 Stryker Corporation
6. Bylaag
6.1 Oor StrategyHelix
6.2 Vrywaring